431 related articles for article (PubMed ID: 15986128)
1. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.
Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S
Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128
[TBL] [Abstract][Full Text] [Related]
2. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.
Kubota A; Yamada Y; Kagimoto S; Shimatsu A; Imamura M; Tsuda K; Imura H; Seino S; Seino Y
J Clin Invest; 1994 Mar; 93(3):1321-5. PubMed ID: 8132773
[TBL] [Abstract][Full Text] [Related]
3. Expression of somatostatin receptor (SSTR) subtypes in pituitary adenomas: quantitative analysis of SSTR2 mRNA by reverse transcription-polymerase chain reaction.
Murabe H; Shimatsu A; Ihara C; Mizuta H; Nakamura Y; Nagata I; Kikuchi H; Nakao K
J Neuroendocrinol; 1996 Aug; 8(8):605-10. PubMed ID: 8866248
[TBL] [Abstract][Full Text] [Related]
4. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization.
Reubi JC; Schaer JC; Waser B; Mengod G
Cancer Res; 1994 Jul; 54(13):3455-9. PubMed ID: 8012966
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin and its receptor family.
Patel YC
Front Neuroendocrinol; 1999 Jul; 20(3):157-98. PubMed ID: 10433861
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor subtype 5 (SSTR5) mRNA expression is related to histopathological features of cell proliferation in insulinomas.
de Sá SV; Corrêa-Giannella ML; Machado MC; de Souza JJ; Pereira MA; Patzina RA; Siqueira SA; Machado MC; Giannella-Neto D
Endocr Relat Cancer; 2006 Mar; 13(1):69-78. PubMed ID: 16601280
[TBL] [Abstract][Full Text] [Related]
7. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in breast carcinoma by real-time polymerase chain reaction.
Iwao K; Miyoshi Y; Egawa C; Ikeda N; Tsukamoto F; Noguchi S
Cancer; 2000 Oct; 89(8):1732-8. PubMed ID: 11042568
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of somatostatin (SST) receptor type 5 (SSTR5) is associated with sexually dimorphic changes in the expression of SST and SST receptors in brain and pancreas.
Ramírez JL; Grant M; Norman M; Wang XP; Moldovan S; de Mayo FJ; Brunicardi C; Kumar U
Mol Cell Endocrinol; 2004 Jun; 221(1-2):105-19. PubMed ID: 15223137
[TBL] [Abstract][Full Text] [Related]
10. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
Xu Y; Yao L; Li H; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Larsson O; Xie Y
Breast Cancer Res Treat; 2006 May; 97(1):49-55. PubMed ID: 16319978
[TBL] [Abstract][Full Text] [Related]
11. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
[TBL] [Abstract][Full Text] [Related]
12. Colocalization of somatostatin receptor subtypes (SSTR1-5) with somatostatin, NADPH-diaphorase (NADPH-d), and tyrosine hydroxylase in the rat hypothalamus.
Kumar U
J Comp Neurol; 2007 Sep; 504(2):185-205. PubMed ID: 17626271
[TBL] [Abstract][Full Text] [Related]
13. Metallothionein 1E mRNA is highly expressed in oestrogen receptor-negative human invasive ductal breast cancer.
Jin R; Bay BH; Chow VT; Tan PH; Lin VC
Br J Cancer; 2000 Aug; 83(3):319-23. PubMed ID: 10917545
[TBL] [Abstract][Full Text] [Related]
14. Expression of a repressor of estrogen receptor activity in human breast tumors: relationship to some known prognostic markers.
Simon SL; Parkes A; Leygue E; Dotzlaw H; Snell L; Troup S; Adeyinka A; Watson PH; Murphy LC
Cancer Res; 2000 Jun; 60(11):2796-9. PubMed ID: 10850416
[TBL] [Abstract][Full Text] [Related]
15. Phospholipid hydroperoxide glutathione peroxidase (PHGPx) expression is downregulated in poorly differentiated breast invasive ductal carcinoma.
Cejas P; García-Cabezas MA; Casado E; Belda-Iniesta C; De Castro J; Fresno JA; Sereno M; Barriuso J; Espinosa E; Zamora P; Feliu J; Redondo A; Hardisson DA; Renart J; González-Barón M
Free Radic Res; 2007 Jun; 41(6):681-7. PubMed ID: 17516241
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells.
Watt HL; Kharmate GD; Kumar U
Cell Signal; 2009 Mar; 21(3):428-39. PubMed ID: 19070659
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of hMAM mRNA detection in bone marrow of breast carcinoma patient].
Li BJ; Wang JY; Wang HY; Huang XP; Zhang LJ; Long H; Yang MT; Rong TH
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):766-9. PubMed ID: 17366790
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin regulates somatostatin receptor subtype mRNA expression in GH3 cells.
Bruno JF; Xu Y; Berelowitz M
Biochem Biophys Res Commun; 1994 Aug; 202(3):1738-43. PubMed ID: 7914724
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin receptor gene expression in human ocular tissues: RT-PCR and immunohistochemical study.
Klisovic DD; O'Dorisio MS; Katz SE; Sall JW; Balster D; O'Dorisio TM; Craig E; Lubow M
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2193-201. PubMed ID: 11527930
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast*.
Zhang Z; Yamashita H; Toyama T; Sugiura H; Ando Y; Mita K; Hamaguchi M; Hara Y; Kobayashi S; Iwase H
Breast Cancer Res Treat; 2005 Nov; 94(1):11-6. PubMed ID: 16172792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
